|
|
| Phases of Development | Preclinical | Pilot | Phase II | Phase II/III | Phase III | Registration | Marketed |
|---|
| Autoimmune | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Cardiovascular | 0 | 0 | 0 | 0 | 5 | 1 | 9 | | Endocrine / Metabolic | 0 | 0 | 1 | 0 | 1 | 1 | 12 | | Infectious | 1 | 1 | 0 | 1 | 0 | 0 | 0 | | Neurology | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Other | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
|
|
Products Targeting HMG-CoA reductase